Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Catalyst Bio (CBIO)

Catalyst Bio (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Catalyst Bio 611 GATEWAY BLVD. SUITE 710 SOUTH SAN FRANCISCO CA 94080 USA

www.catalystbiosciences.com P: 650-871-0761

Description:

Catalyst Biosciences, Inc. is a biopharmaceutical company which focused on creating and developing medicines to address serious medical conditions. The Company's hemostasis product candidates include CB 813d/PF-0520602, CB 2679d/ISU 304 and FXa. Anti-Complement Product consists of CB 2782 and Ophthalmic which are in clinical different trail. Catalyst Biosciences, Inc., formerly known as Targacept, Inc., is based in South San Francisco, Calif.

Key Statistics

Overview:

Market Capitalization, $K 19,418
Enterprise Value, $K 31,058
Shares Outstanding, K 37,978
Annual Sales, $ 790 K
Annual Net Income, $ -8,240 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,580 K
EBIT, $ -44,250 K
EBITDA, $ -44,020 K
60-Month Beta 1.05
% of Insider Shareholders 2.92%
% of Institutional Shareholders 5.98%
Float, K 36,869
% Float 97.08%
Short Volume Ratio 0.54

Growth:

1-Year Return -11.97%
3-Year Return -90.75%
5-Year Return -94.95%
5-Year Revenue Growth -22.55%
5-Year Earnings Growth 72.08%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.04 on 10/26/23
Next Earnings Date 11/13/23
Earnings Per Share ttm -1.50
EPS Growth vs. Prev Qtr 42.86%
EPS Growth vs. Prev Year 75.00%
Annual Dividend Yield 0.00%
Most Recent Dividend 0.569 on 08/20/15
Next Ex-Dividends Date 08/20/15
Dividend Payable Date 08/19/15
Dividend Payout Ratio 18.50%
Most Recent Split 1-15 on 10/31/23

CBIO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -281.68%
Profit Margin % -1,043.04%
Debt/Equity 0.00
Price/Sales 25.12
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.09
Interest Coverage 0.00

CBIO Dividends

Date Value
08/20/15 $0.5690
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar